GlassScriptPhysician profile
William R Reilly
NPI 1205846516
$6,930.06
in general payments reported to CMS, 2019-2025
25 companies · $46.02 in 2025
The $46.02 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,893 · 2020: $395 · 2021: $639 · 2022: $1,484 · 2023: $237 · 2024: $236 · 2025: $46.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $3,981.96 | 2019-2025 | Zero Gravity, Biomonitor |
| Boston Scientific Corporation | $603.00 | 2019-2022 | |
| Amgen INC. | $551.82 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $531.45 | 2019-2022 | |
| Philips North America LLC | $229.00 | 2020-2024 | (Bk5) Azurion 5 M20 |
| Impulse Dynamics (USA) INC. | $193.49 | 2022-2023 | Optimizer |
| Novartis Pharmaceuticals Corporation | $147.34 | 2021-2024 | |
| Watermark Medical, INC. | $146.65 | 2022 | |
| Cardinal Health 200 LLC | $95.38 | 2019 | |
| Cvrx, INC. | $62.22 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $55.35 | 2022-2023 | Eliquis |
| Ge Healthcare | $53.09 | 2019-2024 | |
| Cardiovascular Systems INC. | $38.66 | 2019-2020 | |
| Allergan, INC. | $35.54 | 2019 | |
| Sanofi-Aventis U.S. LLC | $31.73 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $29.94 | 2023 | Acuson Sequoia Diagnostic Ultrasound System |
| Abiomed | $20.43 | 2022 | |
| Medtronic Vascular, INC. | $18.28 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.06 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.03 | 2020 | |
| Merck Sharp & Dohme LLC | $15.66 | 2022 | |
| Angiodynamics, INC. | $14.38 | 2020 | |
| Irhythm Technologies, INC. | $14.10 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.05 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Reilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.